Origin of Elevated S-Glutathionylated GAPDH in Chronic Neurodegenerative Diseases
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065529 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Paul A Hyslop und 2 weiteren Autor:innen. Beteiligte Einrichtung: Arkley Research Laboratories, Arkley BioTek, LLC, 4444 Decatur Blvd., Indianapolis, IN 46241, USA. Hauptthemen laut MEDLINE: Hydrogen Peroxide, Neurodegenerative Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
H2O2-oxidized glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalytic cysteine residues (Cc(SH) undergo rapid S-glutathionylation. Restoration of the enzyme activity is accomplished by thiol/disulfide SN2 displacement (directly or enzymatically) forming glutathione disulfide (G(SS)G) and active enzyme, a process that should be facile as Cc(SH) reside on the subunit surface. As S-glutathionylated GAPDH accumulates following ischemic and/or oxidative stress, in vitro/silico approaches have been employed to address this paradox. Cc(SH) residues were selectively oxidized and S-glutathionylated. Kinetics of GAPDH dehydrogenase recovery demonstrated that glutathione is an ineffective reactivator of S-glutathionylated GAPDH compared to dithiothreitol. Molecular dynamic simulations (MDS) demonstrated strong binding interactions between local residues and S-glutathione. A second glutathione was accommodated for thiol/disulfide exchange forming a tightly bound glutathione disulfide G(SS)G. The proximal sulfur centers of G(SS)G and Cc(SH) remained within covalent bonding distance for thiol/disulfide exchange resonance. Both these factors predict inhibition of dissociation of G(SS)G, which was verified by biochemical analysis. MDS also revealed that both S-glutathionylation and bound G(SS)G significantly perturbed subunit secondary structure particularly within the S-loop, region which interacts with other cellular proteins and mediates NAD(P)+ binding specificity. Our data provides a molecular rationale for how oxidative stress elevates S-glutathionylated GAPDH in neurodegenerative diseases and implicates novel targets for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Arkley Research Laboratories, Arkley BioTek, LLC, 4444 Decatur Blvd., Indianapolis, IN 46241, USA.
- Eli Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA.
ORCID-Profile: Paul A Hyslop
Zitieren
APA
Hyslop, P. A., Boggs, L. N., & Chaney, M. O. (2023). Origin of Elevated S-Glutathionylated GAPDH in Chronic Neurodegenerative Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065529
Vancouver
Hyslop PA, Boggs LN, Chaney MO. Origin of Elevated S-Glutathionylated GAPDH in Chronic Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065529
BibTeX
@article{Hyslop2023,
author = {Hyslop, Paul A and Boggs, Leonard N and Chaney, Michael O},
title = {Origin of Elevated S-Glutathionylated GAPDH in Chronic Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065529}
}
EUVIMED